CN104435243A - Traditional Chinese medicine composition for treating jaundice - Google Patents

Traditional Chinese medicine composition for treating jaundice Download PDF

Info

Publication number
CN104435243A
CN104435243A CN201410810420.6A CN201410810420A CN104435243A CN 104435243 A CN104435243 A CN 104435243A CN 201410810420 A CN201410810420 A CN 201410810420A CN 104435243 A CN104435243 A CN 104435243A
Authority
CN
China
Prior art keywords
chinese medicine
medicine composition
jaundice
traditional chinese
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201410810420.6A
Other languages
Chinese (zh)
Other versions
CN104435243B (en
Inventor
刘百祥
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201410810420.6A priority Critical patent/CN104435243B/en
Publication of CN104435243A publication Critical patent/CN104435243A/en
Application granted granted Critical
Publication of CN104435243B publication Critical patent/CN104435243B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/75Rutaceae (Rue family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/284Atractylodes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/60Moraceae (Mulberry family), e.g. breadfruit or fig
    • A61K36/605Morus (mulberry)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/68Plantaginaceae (Plantain Family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/71Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/74Rubiaceae (Madder family)
    • A61K36/744Gardenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a traditional Chinese medicine composition for treating jaundice. The traditional Chinese medicine composition for treating jaundice is prepared from the following medicinal raw materials: the root of Chinese pulsatilla, ramulus mori, oriental wormwood, cape jasmine, white atractylodes rhizome, plantain herb and cortex dictamni in the mass ratio of (1-3):(1-1.5):(1-3):(1-2):1:(1-2):(1-2). According to the invention, damp heat stasis toxin is used as the main pathogenesis and the starting point of jaundice; the traditional Chinese medicine composition has the effects of detoxifying, removing jaundice, clearing depression and removing dampness; the traditional Chinese medicine composition disclosed by the invention can be used in manners of medicated bath, fuming and washing; the treatment purpose can also be achieved through foot bath and wet packing; the traditional Chinese medicine composition is unnecessary to be taken orally; therefore, burden of liver and kidney is avoided; and the traditional Chinese medicine composition is also widely applied to neonatal jaundice and jaundice patients caused by other various reasons.

Description

A kind of Chinese medicine composition being used for the treatment of jaundice
Technical field
The invention belongs to technical field of Chinese medicines, be specifically related to a kind of Chinese medicine composition being used for the treatment of jaundice.
Background technology
Jaundice a kind ofly raises the sings and symptoms causing skin, mucosa and sclera to turn to be yellow due to serum mesobilirubin, is mostly the dispersivity inflammation of liver parenchymal cell.Clinical signs is that sclera, mucosa, skin and hetero-organization thereof are dyed to yellow.Comparatively general with hepatocellular jaundice and obstructive jaundice in China adult, be common in viral hepatitis, toxic hepatitis, drug-induced liver disease, various liver cirrhosis, former with secondary liver cancer and cholelithiasis etc.Current Western medicine there is no the medicine carrying out effectively treatment for jaundice.
Summary of the invention
The object of this invention is to provide a kind of Chinese medicine composition of effective treatment jaundice.
Technical scheme of the present invention is: a kind of Chinese medicine composition being used for the treatment of jaundice, is prepared from by the crude drug comprising following mass ratio: the Radix Pulsatillae: Ramulus Mori: Herba Artemisiae Scopariae: Fructus Gardeniae: the Rhizoma Atractylodis Macrocephalae: Herba Plantaginis: Cortex Dictamni=(1 ~ 3): (1 ~ 1.5): (1 ~ 3): (1 ~ 2): 1:(1 ~ 2): (1 ~ 2).
The preferred Radix Pulsatillae: Ramulus Mori: Herba Artemisiae Scopariae: Fructus Gardeniae: the Rhizoma Atractylodis Macrocephalae: Herba Plantaginis: Cortex Dictamni=3:1:3:1:1:2:1.5 or 3:1:3:2:1:2:1.
Above-mentioned composition also comprises acceptable adjuvant in pharmacy, and preparation is granule or mixture.Said composition is external.
Said composition is decocted with water by described crude drug, filter and make.Or filtrate is concentrated into paste, add adjuvant and make granule.
The each crude drug effect of the present composition is respectively:
The Radix Pulsatillae: heat-clearing and toxic substances removing, eliminating pathogenic heat from blood to cure dysentery, removing dampness and killing parasites, pharmacological research shows to have antibacterial, antiviral effect;
Ramulus Mori: wind-damp dispelling, the meridian dredging, row aqueous vapor, pharmacological research shows to improve lymhocyte transformation rate, and the Ramulus Mori patient low to lymhocyte transformation rate has certain therapeutical effect;
Herba Artemisiae Scopariae: the effect with clearing away damp-heat, jaundice eliminating subcutaneous ulcer, especially obvious to the effect of infectious jaundice type hepatitis, clinical pharmacology research shows that Herba Artemisiae Scopariae can promote the excretion of bile, alleviate biliary is smouldered, and promotes bilirubinic discharge, protection hepatocyte, promote liver cell regeneration, strengthen the functions of expelling toxin of liver;
Fructus Gardeniae: there is clearing away heat-damp and promoting diuresis, effect that removing pathogenic heat from blood and toxic substance from the body, function of gallbladder promoting protect the liver, Fructus Gardeniae can promote bile secretion, has effect of anti-hyperbilirubinemia;
The Rhizoma Atractylodis Macrocephalae: there is the effect such as invigorating the spleen and benefiting QI, dampness diuretic, modern pharmacological research shows that Rhizoma Atractylodis polysaccharide has the effect improving immunity of organisms and antioxidation, alleviate viral hepatic injury, has benefit during full side is rushed down, eliminating evil and just do not hinder;
Herba Plantaginis: there is clearing away heat and promoting diuresis, effect of removing pathogenic heat from blood and toxic substance from the body, modern pharmacological research confirms, the ursolic acid contained in Herba Plantaginis and cupreol have anti-inflammation and antineoplastic effect;
Cortex Dictamni: heat clearing and damp drying, removing toxic substances of dispeling the wind, has antibacterial, anticancer effect.
The present invention, using hot and humid ecchymosis as the topmost pathogenesis of jaundice and starting point, has removing toxic substances jaundice eliminating, effect of clear strongly fragrant dehumidifying.The lotion of said composition uses Chinese medicinal granule preparation, and its main route of administration is external treatment percutaneous dosing, and skin area is large, and pore is many, apart from outside barrier action, also has the effects such as excretion and Transdermal absorption.Medicine absorbs by transhipments such as mucocutaneous, sweat gland, hair follicle, horny layer, cell and gaps thereof.Administrated method of the present invention can be Traditional Chinese medicine medicated bath, Chinese medicine fumigation and washing, also can reach therapeutic purposes by foot bath and stain of becoming soaked with sweat, without the need to oral, avoid Liver and kidney to bear, now be widely used in neonatal jaundice and the Patients with Jaundice caused by other a variety of causes.
Detailed description of the invention
Embodiment 1
By weight: the Radix Pulsatillae 1 part, Ramulus Mori 1 part, Herba Artemisiae Scopariae 1 part, Fructus Gardeniae 1 part, the Rhizoma Atractylodis Macrocephalae 1 part, Herba Plantaginis 1 part, Cortex Dictamni 1 part.
Embodiment 2
By weight: the Radix Pulsatillae 2 parts, Ramulus Mori 1 part, Herba Artemisiae Scopariae 2 parts, Fructus Gardeniae 1 part, the Rhizoma Atractylodis Macrocephalae 1 part, Herba Plantaginis 1 part, Cortex Dictamni 1 part.
Embodiment 3
By weight: the Radix Pulsatillae 3 parts, Ramulus Mori 1 part, Herba Artemisiae Scopariae 3 parts, Fructus Gardeniae 2 parts, the Rhizoma Atractylodis Macrocephalae 1 part, Herba Plantaginis 2 parts, Cortex Dictamni 2 parts.
Embodiment 4
By weight: the Radix Pulsatillae 3 parts, Ramulus Mori 1.5 parts, Herba Artemisiae Scopariae 3 parts, Fructus Gardeniae 2 parts, the Rhizoma Atractylodis Macrocephalae 1 part, Herba Plantaginis 2 parts, Cortex Dictamni 2 parts.
Embodiment 5
By weight: the Radix Pulsatillae 3 parts, Ramulus Mori 1 part, Herba Artemisiae Scopariae 3 parts, Fructus Gardeniae 1 part, the Rhizoma Atractylodis Macrocephalae 1 part, Herba Plantaginis 2 parts, Cortex Dictamni 1.5 parts.
Embodiment 6
By weight: the Radix Pulsatillae 3 parts, Ramulus Mori 1 part, Herba Artemisiae Scopariae 3 parts, Fructus Gardeniae 2 parts, the Rhizoma Atractylodis Macrocephalae 1 part, Herba Plantaginis 2 parts, Cortex Dictamni 1 part.
Said medicine can be made granule or mixture.Concrete preparation method, for said medicine to be decocted with water, is filtered, is made mixture.Filtrate can be concentrated into paste, add dextrin, granule made by sucrose.Administrated method of the present invention is: dipping; Or Chinese medicine fumigation and washing; Or foot bath; Or stain of becoming soaked with sweat.
Clinical case:
Certain patient, women, 65 years old, on May 13rd, 2012 because of carcinoma of gallbladder recurrence in postoperative 6 months, Intrahepatic metastasis occurred that jaundice was examined over 7 days, see when being admitted to hospital that yellowish body, yellow sclera are obvious; yellow urine brown, liver function test: total bilirubin 104.1 μm of ol/L, bilirubin direct 78.4 μm of ol/L; glutamate pyruvate transaminase 519U/L, GOT2 92U/L.Western medicine diagnose is carcinoma of gallbladder late period, hepatic metastases, liver failure.Infused, Supporting Therapy of suiting the medicine to the illness, by embodiment 5, every part is 10g, decocting 1500ml medicinal liquid, and whole skin is cleaned, every day 1 time.Liver function is checked, total bilirubin 44.7 μm of ol/L, bilirubin direct 28.9 μm of ol/L, glutamate pyruvate transaminase 209U/L, glutamic oxaloacetic transaminase, GOT 97U/L after 7 days.Icteric index declines, and Hepatic function improvement is obvious.
Observe neonate 120 example of obstetrics' birth, all at second day of birth, conventional application is according to embodiment 6 weight ratio, and the Compatible Granule made, specification 29 grams/bag, warm water 3000ml, is dissolved into medicinal liquid, bathing whole body, every day 1 time, each 10 minutes.Controlled observation does not use the neonate of this Chinese medicine, compares 3 days, and after finding this lotion of application, Transcutaneous bilirubin, meconium turn the yellow time than the neonate not having to use rapidly, prove that said preparation can reduce neonatal jaundice.

Claims (7)

1. being used for the treatment of a Chinese medicine composition for jaundice, it is characterized in that the crude drug by comprising following mass ratio is prepared from: the Radix Pulsatillae: Ramulus Mori: Herba Artemisiae Scopariae: Fructus Gardeniae: the Rhizoma Atractylodis Macrocephalae: Herba Plantaginis: Cortex Dictamni=(1 ~ 3): (1 ~ 1.5): (1 ~ 3): (1 ~ 2): 1:(1 ~ 2): (1 ~ 2).
2. the Chinese medicine composition being used for the treatment of jaundice according to claim 1, is characterized in that the Radix Pulsatillae: Ramulus Mori: Herba Artemisiae Scopariae: Fructus Gardeniae: the Rhizoma Atractylodis Macrocephalae: Herba Plantaginis: Cortex Dictamni=3:1:3:1:1:2:1.5 or 3:1:3:2:1:2:1.
3. the Chinese medicine composition being used for the treatment of jaundice according to claim 1 and 2, characterized by further comprising acceptable adjuvant in pharmacy.
4. the Chinese medicine composition being used for the treatment of jaundice according to claim 3, is characterized in that preparation is granule or mixture.
5. the Chinese medicine composition being used for the treatment of jaundice according to claim 1 and 2, is characterized in that said composition is external.
6. the Chinese medicine composition being used for the treatment of jaundice according to claim 1 and 2, is characterized in that said composition is decocted with water by described crude drug, filters and make.
7. the Chinese medicine composition being used for the treatment of jaundice according to claim 6, is characterized in that filtrate to be concentrated into paste, adds adjuvant and make granule.
CN201410810420.6A 2014-12-24 2014-12-24 A kind of Chinese medicine composition being used for the treatment of jaundice Active CN104435243B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410810420.6A CN104435243B (en) 2014-12-24 2014-12-24 A kind of Chinese medicine composition being used for the treatment of jaundice

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410810420.6A CN104435243B (en) 2014-12-24 2014-12-24 A kind of Chinese medicine composition being used for the treatment of jaundice

Publications (2)

Publication Number Publication Date
CN104435243A true CN104435243A (en) 2015-03-25
CN104435243B CN104435243B (en) 2015-12-09

Family

ID=52882505

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410810420.6A Active CN104435243B (en) 2014-12-24 2014-12-24 A kind of Chinese medicine composition being used for the treatment of jaundice

Country Status (1)

Country Link
CN (1) CN104435243B (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105287955A (en) * 2015-11-09 2016-02-03 张健 Traditional Chinese medicine preparation used for treating jaundice and preparation method
CN105749060A (en) * 2016-03-30 2016-07-13 郑州市中医院 Traditional Chinese medicine composition for treating fetal jaundice
CN105944032A (en) * 2016-06-27 2016-09-21 上海长海医院 Traditional Chinese medicine composition for treating intrahepatic cholestatic jaundice diseases and application thereof
CN106344730A (en) * 2016-08-30 2017-01-25 济南市儿童医院 Traditional Chinese medicine composition for treating neonatal jaundice and preparation method thereof
CN110538237A (en) * 2019-09-10 2019-12-06 杨环宇 Chinese herbal medicine bath and preparation method thereof
CN114130058A (en) * 2021-11-19 2022-03-04 云南鸿翔圣琪儿科技有限公司 Traditional Chinese medicine composition for treating jaundice, preparation method and preparation equipment thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102048869A (en) * 2009-10-28 2011-05-11 王宝凤 TCM prescription for treating jaundice of newborn

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102048869A (en) * 2009-10-28 2011-05-11 王宝凤 TCM prescription for treating jaundice of newborn

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
银羽: "茵陈汤治疗新生儿黄疸疗效观察", 《邯郸医学高等专科学校学报》 *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105287955A (en) * 2015-11-09 2016-02-03 张健 Traditional Chinese medicine preparation used for treating jaundice and preparation method
CN105749060A (en) * 2016-03-30 2016-07-13 郑州市中医院 Traditional Chinese medicine composition for treating fetal jaundice
CN105944032A (en) * 2016-06-27 2016-09-21 上海长海医院 Traditional Chinese medicine composition for treating intrahepatic cholestatic jaundice diseases and application thereof
CN105944032B (en) * 2016-06-27 2020-09-08 上海长海医院 Traditional Chinese medicine composition for treating intrahepatic cholestatic jaundice diseases and application thereof
CN106344730A (en) * 2016-08-30 2017-01-25 济南市儿童医院 Traditional Chinese medicine composition for treating neonatal jaundice and preparation method thereof
CN110538237A (en) * 2019-09-10 2019-12-06 杨环宇 Chinese herbal medicine bath and preparation method thereof
CN114130058A (en) * 2021-11-19 2022-03-04 云南鸿翔圣琪儿科技有限公司 Traditional Chinese medicine composition for treating jaundice, preparation method and preparation equipment thereof

Also Published As

Publication number Publication date
CN104435243B (en) 2015-12-09

Similar Documents

Publication Publication Date Title
CN104435243B (en) A kind of Chinese medicine composition being used for the treatment of jaundice
CN102166278B (en) Chinese medicinal composition for treating pediatric rheumatoid arthritis and preparation method thereof
CN101129636A (en) Medicine for treating nasal inflammation
CN100420454C (en) Pharmaceutical composition for treating apoplexy and preparation method thereof
CN103845429A (en) Traditional Chinese medicine for treating chronic hepatitis
CN103251800B (en) Traditional Chinese medicine composition for treating allergic dermatitis
CN105395755A (en) Internal medicine for treating allergic rhinitis
CN106334171B (en) A kind of Chinese medicine preparation and preparation method for being used to repair hepatic injury
CN103536850A (en) Traditional Chinese medicine for treating verruca plana from inside and outside
CN103908600A (en) Externally-applied medicine for treating rheumatoid arthritis damp-heat blockage symptom as well as preparation method and administration method thereof
CN103463391B (en) Pharmaceutical composition for treating chronic pelvic inflammation and application thereof
CN103251900B (en) Drug for treating dysmenorrhea
CN105521437A (en) Spider and emei pueraria flower hemorrhoid-treating gel and preparation method thereof
CN105456924A (en) Traditional Chinese medicine preparation containing Folium Artemisiae Argyi and having functions of promoting circulation and removing stasis and preparation method thereof
CN104225282A (en) Traditional Chinese medicine for treating postpartum headache
CN103610944A (en) Blood circulation promoting and blood stasis removing wine
CN103120768A (en) Medicament for treating vital myocarditis and cardiomyopathy
CN107982462A (en) A kind of external use liquid for treating ringworm of the body
CN101983712A (en) Novel medicament for treating coronary heart disease
CN105288436A (en) Medicament for treatment of chronic eczema
CN105267939A (en) Traditional Chinese medicine composition for treating superficial phlebitis
CN105456447A (en) Folium artemisiae argyi-containing traditional Chinese medicine composition with function of promoting blood circulation to remove stasis and preparation method thereof
CN104056060A (en) Traditional Chinese medicine for treating primary biliary cirrhosis
CN106138718A (en) A kind of preparation method treating enteritis Chinese medicine
CN104189224A (en) Yao medicine composition for treating liver diseases and preparation method of yao medicine

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant